Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Argirò

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Global Cardiology Science & Practice|February 18, 2021
The coronary microcirculation in sepsis: not of micro-importanceAlessia Argirò, Iacopo Olivotto
JACC. Heart Failure|June 13, 2026
Hypertrophic Cardiomyopathy in the Genomic Era: Genetic Testing Is No Longer OptionalAlessia Argirò, Quan M Bui
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Gene therapy for heart failure and cardiomyopathiesAlessia Argirò, Jeffrey Ding, Eric Adler
Revista Espanola De Cardiologia (English Ed.)|March 30, 2024
In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease. ResponseAlessia Argirò, Jeffrey Ding, Eric Adler
Echocardiography (Mount Kisco, N.Y.)|July 12, 2020
Papillary fibroelastoma of the right atrial appendage: Is it that rare?Giuseppe Pilato, Alessia Argirò, Giuseppe Barletta, et al.
Internal and Emergency Medicine|February 9, 2022
SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients seriesMattia Zampieri, Alessia Argirò, Marco Allinovi, et al.
International Journal of Cardiology|October 26, 2024
Left ventricular late gadolinium enhancement for prediction of atrial fibrillation in hypertrophic cardiomyopathy: A good neighbour warns of the dangerAnnamaria Del Franco, Alessia Argirò, Giacomo Bonacchi, et al.
Heart Failure Clinics|June 6, 2024
Standard Therapy in Cardiac Amyloidosis: What is Known, What is "Gray"Annamaria Del Franco, Giulia Biagioni, Carlotta Mazzoni, et al.
Nature Reviews. Disease Primers|August 14, 2025
Hypertrophic cardiomyopathyAlessia Argirò, Victoria Parikh, Ruxandra Jurcut, et al.
International Journal of Cardiology|September 21, 2022
Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgeryPierluigi Stefàno, Alessia Argirò, Beatrice Bacchi, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Global Cardiology Science & Practice|February 18, 2021
The coronary microcirculation in sepsis: not of micro-importanceAlessia Argirò, Iacopo Olivotto
JACC. Heart Failure|June 13, 2026
Hypertrophic Cardiomyopathy in the Genomic Era: Genetic Testing Is No Longer OptionalAlessia Argirò, Quan M Bui
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Gene therapy for heart failure and cardiomyopathiesAlessia Argirò, Jeffrey Ding, Eric Adler
Revista Espanola De Cardiologia (English Ed.)|March 30, 2024
In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease. ResponseAlessia Argirò, Jeffrey Ding, Eric Adler
Echocardiography (Mount Kisco, N.Y.)|July 12, 2020
Papillary fibroelastoma of the right atrial appendage: Is it that rare?Giuseppe Pilato, Alessia Argirò, Giuseppe Barletta, et al.
Internal and Emergency Medicine|February 9, 2022
SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients seriesMattia Zampieri, Alessia Argirò, Marco Allinovi, et al.
International Journal of Cardiology|October 26, 2024
Left ventricular late gadolinium enhancement for prediction of atrial fibrillation in hypertrophic cardiomyopathy: A good neighbour warns of the dangerAnnamaria Del Franco, Alessia Argirò, Giacomo Bonacchi, et al.
Heart Failure Clinics|June 6, 2024
Standard Therapy in Cardiac Amyloidosis: What is Known, What is "Gray"Annamaria Del Franco, Giulia Biagioni, Carlotta Mazzoni, et al.
Nature Reviews. Disease Primers|August 14, 2025
Hypertrophic cardiomyopathyAlessia Argirò, Victoria Parikh, Ruxandra Jurcut, et al.
International Journal of Cardiology|September 21, 2022
Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgeryPierluigi Stefàno, Alessia Argirò, Beatrice Bacchi, et al.
Pageof 8